Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Effect of GFA-918 on Serum Triglyceride Levels in Individuals With Elevated Serum Triglyceride
Conditions
Interventions
GFA-918
Placebo
Locations
2
Canada
KGK Science
London, Ontario, Canada
Canadian College of Naturopathic Medicine
Toronto, Ontario, Canada
Start Date
July 13, 2018
Primary Completion Date
December 6, 2021
Completion Date
December 6, 2021
Last Updated
December 22, 2021
Lead Sponsor
BIO-CAT Microbials, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions